These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 21118096)

  • 1. Do we need a new procedure for the assessment of adverse events in anti-migraine clinical trials?
    Amanzio M
    Recent Pat CNS Drug Discov; 2011 Jan; 6(1):41-7. PubMed ID: 21118096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systematic review of adverse events in placebo groups of anti-migraine clinical trials.
    Amanzio M; Corazzini LL; Vase L; Benedetti F
    Pain; 2009 Dec; 146(3):261-269. PubMed ID: 19781854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse effects of medications commonly used in the treatment of migraine.
    Whyte CA; Tepper SJ
    Expert Rev Neurother; 2009 Sep; 9(9):1379-91. PubMed ID: 19769452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A meta-analysis of the placebo response in acute migraine and how this response may be influenced by some of the characteristics of clinical trials.
    Macedo A; Farré M; Baños JE
    Eur J Clin Pharmacol; 2006 Mar; 62(3):161-72. PubMed ID: 16402240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triptans in the Acute Treatment of Migraine: A Systematic Review and Network Meta-Analysis.
    Cameron C; Kelly S; Hsieh SC; Murphy M; Chen L; Kotb A; Peterson J; Coyle D; Skidmore B; Gomes T; Clifford T; Wells G
    Headache; 2015; 55 Suppl 4():221-35. PubMed ID: 26178694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative tolerability of treatments for acute migraine: A network meta-analysis.
    Thorlund K; Toor K; Wu P; Chan K; Druyts E; Ramos E; Bhambri R; Donnet A; Stark R; Goadsby PJ
    Cephalalgia; 2017 Sep; 37(10):965-978. PubMed ID: 27521843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and tolerability of naratriptan for short-term prevention of menstrually related migraine: data from two randomized, double-blind, placebo-controlled studies.
    Mannix LK; Savani N; Landy S; Valade D; Shackelford S; Ames MH; Jones MW
    Headache; 2007; 47(7):1037-49. PubMed ID: 17635595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Network meta-analysis of migraine disorder treatment by NSAIDs and triptans.
    Xu H; Han W; Wang J; Li M
    J Headache Pain; 2016 Dec; 17(1):113. PubMed ID: 27957624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and tolerability of frovatriptan in acute migraine treatment: systematic review of randomized controlled trials.
    Poolsup N; Leelasangaluk V; Jittangtrong J; Rithlamlert C; Ratanapantamanee N; Khanthong M
    J Clin Pharm Ther; 2005 Dec; 30(6):521-32. PubMed ID: 16336284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug safety in acute migraine treatment.
    Tajti J; Majláth Z; Szok D; Csáti A; Vécsei L
    Expert Opin Drug Saf; 2015 Jun; 14(6):891-909. PubMed ID: 25773005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of 1,000 mg effervescent aspirin: individual patient data meta-analysis of three trials in migraine headache and migraine accompanying symptoms.
    Lampl C; Voelker M; Diener HC
    J Neurol; 2007 Jun; 254(6):705-12. PubMed ID: 17406776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nocebo effects and psychotropic drug action.
    Amanzio M
    Expert Rev Clin Pharmacol; 2015 Mar; 8(2):159-61. PubMed ID: 25494811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Marketed oral triptans in the acute treatment of migraine: a systematic review on efficacy and tolerability.
    Pascual J; Mateos V; Roig C; Sanchez-Del-Rio M; Jiménez D
    Headache; 2007 Sep; 47(8):1152-68. PubMed ID: 17883520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sumatriptan plus naproxen for acute migraine attacks in adults.
    Law S; Derry S; Moore RA
    Cochrane Database Syst Rev; 2013 Oct; (10):CD008541. PubMed ID: 24142431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute treatment of migraine attacks: efficacy and safety of a nonsteroidal anti-inflammatory drug, diclofenac-potassium, in comparison to oral sumatriptan and placebo. The Diclofenac-K/Sumatriptan Migraine Study Group.
    Cephalalgia; 1999 May; 19(4):232-40. PubMed ID: 10376168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and tolerability of short-term preventive frovatriptan: a combined analysis.
    MacGregor EA; Brandes JL; Silberstein S; Jeka S; Czapinski P; Shaw B; Pawsey S
    Headache; 2009 Oct; 49(9):1298-314. PubMed ID: 19788471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute management of migraine.
    Chowdhury D
    J Assoc Physicians India; 2010 Apr; 58 Suppl():21-5. PubMed ID: 21049703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Focus on trial endpoints of clinical relevance and the use of almotriptan for the acute treatment of migraine.
    Sandrini G; Dahlöf CG; Mathew N; Nappi G
    Int J Clin Pract; 2005 Nov; 59(11):1356-65. PubMed ID: 16236092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symptomatic treatment of migraine in children: a systematic review of medication trials.
    Damen L; Bruijn JK; Verhagen AP; Berger MY; Passchier J; Koes BW
    Pediatrics; 2005 Aug; 116(2):e295-302. PubMed ID: 16061583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Migraine therapeutics in adolescents: a systematic analysis and historic perspectives of triptan trials in adolescents.
    Sun H; Bastings E; Temeck J; Smith PB; Men A; Tandon V; Murphy D; Rodriguez W
    JAMA Pediatr; 2013 Mar; 167(3):243-9. PubMed ID: 23359002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.